Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

SPRB

Spruce Biosciences (SPRB)

Spruce Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SPRB
DateTimeSourceHeadlineSymbolCompany
06/06/202422:00Business WireSpruce Biosciences Recognized as a Bay Area Best Place to WorkNASDAQ:SPRBSpruce Biosciences Inc
05/06/202409:27Business Wireスプルース・バイオサイエンスとHMNC Brain Health GmbH、大うつ病性障害(MDD)の治療法開発に向けた戦略的協働を発表NASDAQ:SPRBSpruce Biosciences Inc
05/06/202406:16Business WireSpruce Biosciences und HMNC Brain Health kündigen strategische Zusammenarbeit zur Entwicklung einer Behandlung für Major Depressive Disorder (MDD) anNASDAQ:SPRBSpruce Biosciences Inc
05/06/202406:16Business WireSpruce Biosciences et HMNC Brain Health annoncent une collaboration stratégique pour le développement d’un traitement du trouble dépressif majeur (TDM)NASDAQ:SPRBSpruce Biosciences Inc
04/06/202421:00Business WireSpruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder (MDD)NASDAQ:SPRBSpruce Biosciences Inc
03/06/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPRBSpruce Biosciences Inc
03/06/202421:00Business WireSpruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024NASDAQ:SPRBSpruce Biosciences Inc
25/05/202406:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPRBSpruce Biosciences Inc
25/05/202406:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPRBSpruce Biosciences Inc
25/05/202406:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPRBSpruce Biosciences Inc
25/05/202406:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPRBSpruce Biosciences Inc
25/05/202406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPRBSpruce Biosciences Inc
24/05/202406:05Business WireSpruce Biosciences to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:SPRBSpruce Biosciences Inc
23/05/202406:14Business WireSpruce Biosciences Announces Poster Presentations at the 2024 Annual Meeting of the Endocrine SocietyNASDAQ:SPRBSpruce Biosciences Inc
14/05/202406:09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SPRBSpruce Biosciences Inc
14/05/202406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPRBSpruce Biosciences Inc
14/05/202406:01Business WireSpruce Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesNASDAQ:SPRBSpruce Biosciences Inc
02/05/202406:05Business WireSpruce Biosciences to Participate in May Investor ConferencesNASDAQ:SPRBSpruce Biosciences Inc
01/05/202406:05Business WireSpruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual MeetingNASDAQ:SPRBSpruce Biosciences Inc
23/04/202406:05Business WireSpruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual MeetingNASDAQ:SPRBSpruce Biosciences Inc
14/03/202407:08Business WireSpruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate UpdatesNASDAQ:SPRBSpruce Biosciences Inc
14/03/202407:01Business WireSpruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAHNASDAQ:SPRBSpruce Biosciences Inc
08/03/202408:07Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SPRBSpruce Biosciences Inc
07/02/202408:15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SPRBSpruce Biosciences Inc
31/01/202408:05Business WireSpruce Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:SPRBSpruce Biosciences Inc
23/01/202400:00Business WireSpruce Biosciences Completes Enrollment in CAHmelia-204 Study for Adult Classic Congenital Adrenal HyperplasiaNASDAQ:SPRBSpruce Biosciences Inc
09/01/202400:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPRBSpruce Biosciences Inc
06/01/202400:00Business WireSpruce Biosciences Reports Baseline Characteristics from CAHmelia-203 and CAHmelia-204 Studies in Adult Classic CAHNASDAQ:SPRBSpruce Biosciences Inc
05/01/202400:00Business WireSpruce Biosciences Provides Clinical Program Updates and Outlook for 2024NASDAQ:SPRBSpruce Biosciences Inc
04/01/202408:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPRBSpruce Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:SPRB

Your Recent History

Delayed Upgrade Clock